טוען...
HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants.
BACKGROUND:In China, the combination of homoharringtonine, cytarabine, and G-CSF (HAG) has been extensively applied for treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). METHODS:We performed a meta-analysis of 2,314 patients (AML, n = 1754; MDS, n = 560) to determine the...
שמור ב:
Main Authors: | , , , , , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Public Library of Science (PLoS)
2016-01-01
|
סדרה: | PLoS ONE |
גישה מקוונת: | http://europepmc.org/articles/PMC5051946?pdf=render |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|